다제내성세균에 대한 적극적 감염감시

키워드

참고문헌 (68)

1. National Nosocomial Infections Surveillance System, "National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004", Am J Infect Control, 32, pp.470~485 (2004)
2. Obritsch MD, "National surveillance of antimicrobial resistance in Pseudomonas aeruginosa isolates obtained from intensive care unit patients from 1993 to 2002", Antimicrob Agents Chemother, 48, pp.4606~4610 (2004)
3. Yong D, "Characterization of a new metallo-beta-lactamase gene, blaNDM-1, and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India", Antimicrob Agents Chemother, 53, pp.5046~5054 (2009)
4. Hishinuma A, "New Delhi metallo-beta-lactamase-1 (NDM-1) producing bacteria", Nihon Rinsho, 70, pp.262~266 (2012)
5. Malhotra-Kumar S, "MOSAR WP2 Study Team. Current trends in rapid diagnostics for methicillin-resistant Staphylococcus aureus and glycopeptide-resistant Enterococcus species", J Clin Microbiol, 46, pp.1577~1587 (2008)
6. Ben Nsira S, "Evaluation of MRSA Select, a new chromogenic medium for the detection of nasal carriage of methicillin-resistant Staphylococcus aureus", Int J Antimicrob Agents, 27, pp.561~564 (2006)
7. Compernolle V, "Combined use of Pastorex Staph-Plus and either of two new chromogenic agars, MRSA ID and CHROMagar MRSA, for detection of methicillinresistant Staphylococcus aureus", J Clin Microbiol, 45, pp.154~158 (2007)
8. Louie L, "Evaluation of a new chromogenic medium, MRSA select, for detection of methicillin-resistant Staphylococcus aureus", J Clin Microbiol, 44, pp.4561~4563 (2006)
9. Nahimana I, "Evaluation of three chromogenic media (MRSA-ID, MRSA-Select and CHROMagar MRSA) and ORSAB for surveillance cultures of methicillin-resistant Staphylococcus aureus", Clin Microbiol Infect, 12, pp.1168~1174 (2006)
10. Stoakes L, "Prospective comparison of a new chromogenic medium, MRSASelect, to CHROMagar MRSA and mannitol-salt medium supplemented with oxacillin or cefoxitin for detection of methicillin- resistant Staphylococcus aureus", J Clin Microbiol, 44, pp.637~639 (2006)
11. van Hal SJ, "Methicillin-resistant Staphylococcus aureus (MRSA) detection: comparison of two molecular methods (IDI-MRSA PCR assay and GenoType MRSA Direct PCR assay) with three selective MRSA agars (MRSA ID, MRSASelect, and CHROMagar MRSA) for use with infection-control swabs", J Clin Microbiol, 45, pp.2486~2490 (2007)
12. Cherkaoui A, "Comparison of four chromogenic media for culture-based screening of meticillinresistant Staphylococcus aureus", J Med Microbiol, 56, pp.500~503 (2007)
13. Perry JD, "Development and evaluation of a chromogenic agar medium for methicillin-resistant Staphylococcus aureus", J Clin Microbiol, 42, pp.4519~4523 (2004)
14. Daeschlein G, "Multiplex PCR-ELISA for direct detection of MRSA in nasal swabs advantageous for rapid identification of non-MRSA carriers", Eur J Clin Microbiol Infect Dis, 25, pp.328~330 (2006)
15. Holfelder M, "Direct detection of methicillin-resistant Staphylococcus aureus in clinical specimens by a nucleic acid-based hybridisation assay", Clin Microbiol Infect, 12, pp.1163~1167 (2006)
16. Levi K, "Rapid detection of methicillin-resistant Staphylococcus aureus from screening enrichment broths by realtime PCR", Eur J Clin Microbiol Infect Dis, 24, pp.423~427 (2005)
17. Paule SM, "Performance of the BD GeneOhm methicillinresistant Staphylococcus aureus test before and during high-volume clinical use", J Clin Microbiol, 45, pp.2993~2998 (2007)
18. Wagenvoort JH, "Comparison of an enrichment broth-enhanced commercial PCR procedure versus bacteriological culture for separating non-colonized from suspected or colonized MRSA individuals", Eur J Clin Microbiol Infect Dis, 26, pp.155~160 (2007)
19. Bishop EJ, "Concurrent analysis of nose and groin swab specimens by the IDI-MRSA PCR assay is comparable to analysis by individualspecimen PCR and routine culture assays for detection of colonization by methicillin-resistant Staphylococcus aureus", J Clin Microbiol, 44, pp.2904~2908 (2006)
20. Rossney AS, "Evaluation of the IDI-MRSA assay on the SmartCycler real-time PCR platform for rapid detection of MRSA from screening specimens", Eur J Clin Microbiol Infect Dis, 26, pp.459~466 (2007)
21. Zhang SX, "Comparison of two versions of the IDI-MRSA assay using charcoal swabs for prospective nasal and nonnasal surveillance samples", J Clin Microbiol, 45, pp.2278~2280 (2007)
22. Desjardins M, "Evaluation of the IDI-MRSA assay for detection of methicillinresistant Staphylococcus aureus from nasal and rectal specimens pooled in a selective broth", J Clin Microbiol, 44, pp.1219~1223 (2006)
23. Wolk DM, "Multicenter evaluation of the Cepheid Xpert methicillinresistant Staphylococcus aureus (MRSA) test as a rapid screening method for detection of MRSA in nares", J Clin Microbiol, 47, pp.758~764 (2009)
24. Domingo MC, "High prevalence of glycopeptide resistance genes vanB, vanD, and vanG not associated with enterococci in human fecal flora", Antimicrob Agents Chemother, 49, pp.4784~4786 (2005)
25. Li W, "Bacterial strain typing in the genomic era", FEMS Microbiol Rev, 33, pp.892~916 (2009)
26. Struelens MJ, "Laboratory tools and strategies for methicillin-resistant Staphylococcus aureus screening, surveillance and typing: state of the art and unmet needs", Clin Microbiol Infect, 15, pp.112~119 (2009)
27. Carnevale RJ, "Evaluating the utility of syndromic surveillance algorithms for screening to detect potentially clonal hospital infection outbreaks", J Am Med Inform Assoc, 18, pp.466~472 (2011)
28. Buckeridge DL, "Outbreak detection through automated surveillance: a review of the determinants of detection", J Biomed Inform, 40, pp.370~379 (2007)
29. Jernigan JA, "Anthrax Bioterrorism Investigation Team. Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States", Emerg Infect Dis, 7, pp.933~944 (2001)
30. Centers for Disease Control and Prevention (CDC), "Syndromic surveillance. Reports from a national conference, 2003", MMWR Morb Mortal Wkly Rep, 53(Suppl), pp.1~264 (2003)
31. Centers for Disease Control and Prevention (CDC), "Syndromic surveillance for bioterrorism following the attacks on the World Trade Center--New York City, 2001", MMWR Morb Mortal Wkly Rep, 51, pp.13~15 (2002)
32. Begier EM, "The National Capitol Region's Emergency Department syndromic surveillance system: do chief complaint and discharge diagnosis yield different results?", Emerg Infect Dis, 9, pp.393~396 (2003)
33. Gesteland PH, "Rapid deployment of an electronic disease surveillance system in the state of Utah for the 2002 Olympic Winter Games", Proc AMIA Symp, pp.285~289 (2002)
34. Lazarus R, "Use of automated ambulatory-care encounter records for detection of acute illness clusters, including potential bioterrorism events", Emerg Infect Dis, 8, pp.753~760 (2002)
35. Wagner MM, "The emerging science of very early detection of disease outbreaks", J Public Health Manag Pract, 7, pp.51~59 (2001)
36. Kenner J, "Viscount H, et al. Rates of carriage of methicillin-resistant and methicillin-susceptible Staphylococcus aureus in an outpatient population", Infect Control Hosp Epidemiol, 24, pp.439~444 (2003)
37. van den Braak N, "Prevalence and determinants of fecal colonization with vancomycin-resistant Enterococcus in hospitalized patients in The Netherlands", Infect Control Hosp Epidemiol, 21, pp.520~524 (2000)
38. Coello R, "Risk factors for developing clinical infection with methicillin-resistant Staphylococcus aureus (MRSA) amongst hospital patients initially only colonized with MRSA", J Hosp Infect, 37, pp.39~46 (1997)
39. Huang SS, "Risk of methicillin-resistant Staphylococcus aureus infection after previous infection or colonization", Clin Infect Dis, 36, pp.281~285 (2003)
40. Pujol M, "Risk factors for nosocomial bacteremia due to methicillin-resistant Staphylococcus aureus", Eur J Clin Microbiol Infect Dis, 13, pp.96~102 (1994)
41. Henning KJ, "Vancomycin-resistant Enterococcus faecium on a pediatric oncology ward: duration of stool shedding and incidence of clinical infection", Pediatr Infect Dis J, 15, pp.848~854 (1996)
42. Yeh KM, "Vancomycin-resistant enterococcus (VRE) carriage and infection in intensive care units", Microb Drug Resist, 10, pp.177~183 (2004)
43. Zirakzadeh A, "Vancomycin-resistant enterococci: colonization, infection, detection, and treatment", Mayo Clin Proc, 81, pp.529~536 (2006)
44. Pittet D, "Effectiveness of a hospital-wide programme to improve compliance with hand hygiene. Infection Control Programme", Lancet, 356, pp.1307~1312 (2000)
45. Johnson PD, "Efficacy of an alcohol", chlorhexidine hand hygiene program in a hospital with high rates of nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection, 2005, pp.183, 509~514
46. Rosenthal VD, "Reduction in nosocomial infection with improved hand hygiene in intensive care units of a tertiary care hospital in Argentina", Am J Infect Control, 33, pp.392~397 (2005)
47. Dancer SJ, "MRSA acquisition in an intensive care unit", Am J Infect Control, 34, pp.10~17 (2006)
48. Jernigan JA, "Effectiveness of contact isolation during a hospital outbreak of methicillin-resistant Staphylococcus aureus", Am J Epidemiol, 143, pp.496~504 (1996)
49. Puzniak LA, "To gown or not to gown: the effect on acquisition of vancomycin-resistant enterococci", Clin Infect Dis, 35, pp.18~25 (2002)
50. Karanfil LV, "A cluster of vancomycin-resistant Enterococcus faecium in an intensive care unit", Infect Control Hosp Epidemiol, 13, pp.195~200 (1992)
51. Montecalvo MA, "Outbreak of vancomycin-, ampicillin-, and aminoglycoside- resistant Enterococcus faecium bacteremia in an adult oncology unit", Antimicrob Agents Chemother, 38, pp.1363~1367 (1994)
52. Back NA, "Control of methicillin-resistant Staphylococcus aureus in a neonatal intensivecare unit: use of intensive microbiologic surveillance and mupirocin", Infect Control Hosp Epidemiol, 17, pp.227~231 (1996)
53. Armstrong-Evans M, "Control of transmission of vancomycin-resistant Enterococcus faecium in a long-term-care facility", Infect Control Hosp Epidemiol, 20, pp.312~317 (1999)
54. Byers KE, "A hospital epidemic of vancomycin-resistant Enterococcus: risk factors and control", Infect Control Hosp Epidemiol, 22, pp.140~147 (2001)
55. Saiman L, "An outbreak of methicillin-resistant Staphylococcus aureus in a neonatal intensive care unit", Infect Control Hosp Epidemiol, 24, pp.317~321 (2003)
56. Khoury J, "Eradication of methicillin-resistant Staphylococcus aureus from a neonatal intensive care unit by active surveillance and aggressive infection control measures", Infect Control Hosp Epidemiol, 26, pp.616~621 (2005)
57. Singh N, "Control of vancomycin-resistant enterococci in the neonatal intensive care unit", Infect Control Hosp Epidemiol, 26, pp.646~649 (2005)
58. Mascini EM, "Genotyping and preemptive isolation to control an outbreak of vancomycin-resistant Enterococcus faecium", Clin Infect Dis, 42, pp.739~746 (2006)
59. Huskins WC, "STAR*ICU Trial Investigators. Intervention to reduce transmission of resistant bacteria in intensive care", N Engl J Med, 364, pp.1407~1418 (2011)
60. Dembry LM, "Control of endemic glycopeptide-resistant enterococci", Infect Control Hosp Epidemiol, 17, pp.286~292 (1996)
61. Jochimsen EM, "Control of vancomycin-resistant enterococci at a community hospital: efficacy of patient and staff cohorting", Infect Control Hosp Epidemiol, 20, pp.106~109 (1999)
62. Siddiqui AH, "The effect of active surveillance for vancomycinresistant enterococci in high-risk units on vancomycin-resistant enterococci incidence hospital-wide", Am J Infect Control, 30, pp.40~43 (2002)
63. Huang SS, "Impact of routine intensive care unit surveillance cultures and resultant barrier precautions on hospital-wide methicillin- resistant Staphylococcus aureus bacteremia", Clin Infect Dis, 43, pp.971~978 (2006)
64. Karchmer TB, "Cost-effectiveness of active surveillance cultures and contact", droplet precautions for control of methicillin-resistant Staphylococcus aureus, 2002, pp.51, 126~132
65. Weber SG, "Society for Healthcare Epidemiology of America; Association of Professionals in Infection Control and Epidemiology. Legislative mandates for use of active surveillance cultures to screen for methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: position statement from the Joint SHEA and APIC Task Force", Infect Control Hosp Epidemiol, 28, pp.249~260 (2007)
66. Fraser V, "Boards of Directors of APIC and SHEA. Politically incorrect: legislation must not mandate specific healthcare epidemiology and infection prevention and control practices", Infect Control Hosp Epidemiol, 28, pp.594~595 (2007)
67. Farr BM, "Political versus epidemiological correctness", Infect Control Hosp Epidemiol, 28, pp.589~593 (2007)
68. Harbarth S, "Update on screening and clinical diagnosis of meticillin- resistant Staphylococcus aureus (MRSA)", Int J Antimicrob Agents, 37, pp.110~117 (2011)

관련 논문AI추천